3M agrees to $7.35 bn settlement of PFAS personal‑injury claims

3M (MMM) announced a broad settlement of the Aqueous Film‑Forming Foam multidistrict litigation, committing $7.35 billion in nominal payments over nine years. The agreement covers roughly 99 % of current claims, affecting about 115,000–120,000 plaintiffs, and includes a $680 million reserve for future claims. The present‑value of the commitment is $5.8 billion, which the company will record as a pre‑tax charge in the fourth quarter of 2026. CEO William Brown called the deal a significant milestone that reduces litigation uncertainty, and the settlement does not alter 3M’s 2026 guidance.

The $5.8 billion pre‑tax charge will be reflected as a special item in 3M’s Q4 2026 adjusted results, lowering that quarter’s earnings (the company says the charge will not affect its 2026 guidance). The settlement also quantifies most of the PFAS litigation risk that has weighed on the stock.

  • 13M will make a nominal commitment of $7.35 billion over nine years, with a discounted present value of $5.8 billion.
  • 2The settlement addresses approximately 99 % of current personal‑injury claims, covering about 115,000–120,000 eligible plaintiffs.
  • 3A $680 million reserve is included for remaining and future claims.
  • 4Payments start with $50 million in 2026, none in 2027, and about 20 % of the total due in the final two years.
  • 53M will record a pre‑tax charge of $5.8 billion in the fourth quarter of 2026, treated as a special item in adjusted results.
  • 6The company said the settlement does not change its previously issued 2026 guidance.

Sources